8 employees
Axent Biosciences is a biotech venture that engineers biomaterial technology for the development pipeline of stem cell therapy.
2016
$100K
from 1 investors over 1 rounds
Axent Biosciences raised $100K on August 18, 2020
Investors: Berkeley SkyDeck